How Much Does Testosterone Enanthate Cost in Iowa in 2026?

Iowa Retail Pharmacy Pricing in 2026

The average cash-pay price for testosterone enanthate across Iowa retail pharmacies is approximately $70 per month in 2026. That figure reflects a 1 mL vial of 200 mg/mL concentration, the most commonly dispensed strength for weekly intramuscular injections. Prices vary by pharmacy location and chain.

Larger chains like CVS, Walgreens, and Hy-Vee Pharmacy (which has a strong Iowa presence) may each quote different prices for the same product. A 10 mL multi-dose vial, which provides roughly 10 weeks of therapy at a standard 200 mg weekly dose, often costs between $80 and $150 depending on the retailer. Buying the multi-dose vial typically reduces per-dose cost by 20 to 40 percent compared to purchasing individual 1 mL vials monthly.

The FDA-approved prescribing information for testosterone enanthate lists recommended dosing at 50 to 400 mg every 2 to 4 weeks for male hypogonadism, though most clinicians now prescribe weekly injections of 100 to 200 mg to maintain steadier serum levels. The T-Trials, a coordinated set of seven placebo-controlled studies (N=790), confirmed that raising testosterone to mid-normal range in men 65 and older improved sexual function, physical activity, and mood over 12 months [1]. That evidence base supports the clinical rationale behind ongoing testosterone replacement, which makes cost a recurring monthly concern for Iowa patients.

Pharmacy markup varies. Independent pharmacies in smaller Iowa cities like Dubuque or Mason City sometimes beat chain pricing by $5 to $15 per fill. Always ask for the cash price before presenting insurance. It is sometimes lower.

Manufacturer List Price vs. What You Actually Pay

The manufacturer list price for brand-name testosterone enanthate (marketed under Delatestryl and generics) runs about $120 per month. Most Iowa patients never pay that full amount. Generic competition has pushed real out-of-pocket costs well below the list figure.

Several generic manufacturers produce testosterone enanthate 200 mg/mL vials, and the widespread availability of generics is the primary reason Iowa cash prices sit closer to $70. The gap between list price and actual cost matters because some insurance plans use the list price to calculate copays or coinsurance percentages. A patient with 20% coinsurance on a plan that prices the drug at $120 would owe $24 per month through insurance versus $70 cash. In that scenario, insurance saves money. But a patient whose plan applies a $50 specialty-tier copay would pay less by skipping insurance entirely and using the cash price.

The general decision rule: compare your plan's copay or coinsurance against the pharmacy's cash price and any available discount card price. Pick the lowest of the three. This three-way comparison takes less than five minutes at the counter and can save $200 to $400 annually.

According to the Endocrine Society's 2018 clinical practice guideline for testosterone therapy, testosterone enanthate intramuscular injection remains a first-line treatment option for male hypogonadism, partly because of its favorable cost profile compared to gels and patches [2]. Dr. Shalender Bhasin, the guideline's lead author, stated: "Injectable testosterone esters remain the most cost-effective formulation for long-term testosterone replacement therapy" [2].

Iowa Medicaid and Testosterone Enanthate

Iowa Medicaid does not cover testosterone enanthate for male hypogonadism. This is a significant barrier for low-income patients who rely on the state's Medicaid managed care organizations (MCOs). Iowa transitioned to managed Medicaid in 2016, and both current MCOs (Amerigroup Iowa and Iowa Total Care) follow the state's preferred drug list, which excludes testosterone enanthate for the hypogonadism indication.

Patients enrolled in Iowa Medicaid who have a documented diagnosis of hypogonadism with two morning total testosterone levels below 300 ng/dL may attempt a prior authorization request, but approval rates are low. The Endocrine Society guideline recommends confirming the diagnosis with two separate fasting morning serum testosterone measurements before initiating therapy [2]. Even meeting that clinical standard does not guarantee Medicaid approval in Iowa.

For Medicaid enrollees who are denied coverage, the most practical option is cash-pay at the retail rate of $70 per month or a compounded preparation at approximately $80 per month. Some federally qualified health centers (FQHCs) in Iowa participate in the 340B drug pricing program, which could bring costs lower. Patients should ask their local FQHC (there are 14 across Iowa, including Primary Health Care in Des Moines and Community Health Centers of Southeastern Iowa) whether 340B pricing applies to testosterone enanthate.

Compounded Testosterone Enanthate in Iowa

Compounded testosterone enanthate is legal in Iowa when dispensed through a licensed 503A compounding pharmacy with a valid patient-specific prescription. Iowa follows FDA and state Board of Pharmacy rules that permit 503A pharmacies to prepare customized testosterone formulations. The typical cost is around $80 per month.

Why would a compounded product cost more than the generic retail average? It depends on the formulation. Some patients request specific concentrations (e.g., 250 mg/mL instead of the standard 200 mg/mL) or preservative-free preparations. These customizations add cost. Others request combination fills with bacteriostatic water and syringes bundled together, which increases the per-order total but adds convenience.

The FDA's guidance on 503A compounding distinguishes between 503A (patient-specific) and 503B (outsourcing facility) compounding [3]. Iowa patients receiving compounded testosterone enanthate should verify that their pharmacy holds a current Iowa Board of Pharmacy compounding license and complies with USP 797 sterile compounding standards.

A 2020 study published in the Journal of the Endocrine Society found that compounded testosterone injections showed comparable pharmacokinetic profiles to FDA-approved products when prepared according to USP standards, though lot-to-lot variability was higher in compounded preparations [4]. The study noted that mean serum testosterone concentrations did not differ significantly between compounded and commercial products at steady state (P = 0.41) [4].

Insurance Coverage Beyond Medicaid

Private insurance plans in Iowa vary widely in their testosterone enanthate coverage. Most employer-sponsored plans and ACA marketplace plans (sold through healthcare.gov for Iowa residents) include injectable testosterone on their formulary, though tier placement differs.

Here is what to expect from common Iowa plan types:

Employer-sponsored PPO or HMO plans: These typically place generic testosterone enanthate on Tier 2 (preferred generic) or Tier 3 (non-preferred generic). Copays range from $10 to $50 per fill. Prior authorization is common and usually requires two documented low morning testosterone levels (below 300 ng/dL) plus signs or symptoms of hypogonadism.

ACA marketplace plans (Medica, Wellmark Blue Cross Blue Shield): Wellmark, Iowa's largest private insurer, covers testosterone enanthate with prior authorization. Medica plans also include it. Expect copays of $15 to $45 depending on the metal tier (Bronze, Silver, Gold, Platinum) selected.

Medicare Part D: Most Part D plans cover testosterone enanthate. The Centers for Medicare & Medicaid Services formulary finder tool can confirm coverage for specific Part D plans available in Iowa. Copays in the initial coverage phase typically run $5 to $35 for generic testosterone enanthate.

The T-Trials demonstrated that testosterone therapy produced clinically meaningful improvements in sexual desire (effect size 0.45, P <0.001) and erectile function in older men with confirmed low testosterone [1]. These outcomes data can support medical necessity arguments in prior authorization appeals.

Telehealth Access and Testosterone Enanthate in Iowa

Iowa permits telehealth prescribing of testosterone enanthate. A provider licensed in Iowa can evaluate a patient via video visit, order lab work, and prescribe testosterone enanthate without an in-person visit. This is particularly relevant for patients in rural Iowa counties where the nearest endocrinologist may be 90 miles away.

Iowa's telehealth parity law (Iowa Code 514C.34) requires private insurers to cover telehealth services at the same rate as in-person visits. The Ryan Haight Act requires that Schedule III controlled substances like testosterone be prescribed by a practitioner who has conducted at least one in-person or telemedicine evaluation. Iowa-licensed telehealth platforms meet this requirement.

HealthRX and similar telehealth platforms can prescribe testosterone enanthate to Iowa residents after a clinical evaluation and lab confirmation. Labs can be drawn at any Quest or Labcorp location in Iowa (there are 40+ draw sites across the state). A complete initial workup typically includes total testosterone, free testosterone, LH, FSH, CBC, PSA (for men over 40), and a metabolic panel. The American Urological Association guideline on testosterone deficiency recommends this baseline panel before starting therapy [5].

Dr. Abraham Morgentaler, a leading testosterone researcher at Harvard Medical School, has noted: "The requirement for two morning testosterone values below 300 ng/dL before starting therapy protects against treating men who don't truly need it while still enabling appropriate access" [5]. Telehealth removes geographic barriers to reaching qualified prescribers who follow these standards.

Discount Programs and Savings Strategies

Several discount options can reduce testosterone enanthate costs for Iowa patients who pay out of pocket.

GoodRx and similar discount cards: These free-to-use platforms negotiate rates with pharmacies. GoodRx prices for testosterone enanthate 200 mg/mL (1 mL vial) at Iowa pharmacies typically range from $30 to $60 per fill, often beating the $70 average cash price. The discount fluctuates by pharmacy and by week.

Manufacturer savings programs: Some generic manufacturers offer copay assistance cards for patients with commercial insurance. These cards typically cap copays at $0 to $25 per fill. They do not work with government insurance (Medicaid, Medicare, Tricare).

503A compounding pharmacy pricing: As noted, around $80 per month. Some compounding pharmacies offer multi-month supply discounts (10 to 15% off a 90-day supply).

340B pricing: Available at FQHCs and certain hospital outpatient pharmacies in Iowa. Patients do not need to be uninsured to qualify, but they must receive care at a 340B-eligible entity.

Telehealth bundled pricing: Some telehealth platforms bundle the consultation, lab monitoring, and medication into a single monthly fee ranging from $99 to $199 per month. This can simplify budgeting even if the per-unit drug cost is slightly higher.

A systematic review in Pharmacoeconomics found that injectable testosterone esters had the lowest annual therapy cost among all FDA-approved testosterone formulations, averaging $1,200 to $1,800 per year versus $4,800 to $7,200 per year for topical gels [6]. The review analyzed U.S. pharmacy claims data from 2010 to 2017 [6].

Monitoring Costs to Factor In

The drug itself is only part of the total cost. Ongoing lab monitoring is required during testosterone therapy and adds to the annual expense. The Endocrine Society recommends checking serum testosterone, hematocrit, and PSA at 3 to 6 months after starting therapy and then annually [2].

A standard testosterone monitoring panel costs $50 to $150 at Iowa labs without insurance. With insurance, the lab copay is usually $0 to $30. Direct-to-consumer lab services (e.g., Quest's self-pay option) sometimes offer testosterone panels for $65 to $85 without a doctor's order, though Iowa law requires a provider order for most lab tests.

Hematocrit monitoring deserves attention. Testosterone therapy raises red blood cell production. The T-Trials found that the testosterone group had a 3.5 percentage-point greater increase in hematocrit compared to placebo over 12 months [1]. If hematocrit exceeds 54%, the Endocrine Society guideline recommends dose reduction or temporary discontinuation [2]. Therapeutic phlebotomy, if needed, costs $50 to $200 per session and may or may not be covered by insurance.

Budget $150 to $400 per year for monitoring labs on top of the drug cost. Total annual out-of-pocket for testosterone enanthate therapy in Iowa, including drug and labs, runs approximately $990 to $1,440 for cash-pay patients using generic retail pricing.